Cargando…

Toxoplasma GRA Peptide-Specific Serologic Fingerprints Discriminate Among Major Strains Causing Toxoplasmosis

The severity of toxoplasmosis depends on a combination of host and parasite factors. Among them, the Toxoplasma strain causing the infection is an important determinant of the disease outcome. Type 2 strains dominate in Europe, whereas in North America type 2, followed by type 3 and 12 strains are c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arranz-Solís, David, Carvalheiro, Cristina G., Zhang, Elizabeth R., Grigg, Michael E., Saeij, Jeroen P. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935526/ https://www.ncbi.nlm.nih.gov/pubmed/33680990 http://dx.doi.org/10.3389/fcimb.2021.621738

Ejemplares similares

Toxoplasma Does Not Secrete the GRA16 and GRA24 Effectors Beyond the Parasitophorous Vacuole Membrane of Tissue Cysts
por: Krishnamurthy, Shruthi, et al.
Publicado: (2018)

Serotyping of Toxoplasma gondii Infection Using Peptide Membrane Arrays
por: Arranz-Solís, David, et al.
Publicado: (2019)

Influence of the Host and Parasite Strain on the Immune Response During Toxoplasma Infection
por: Mukhopadhyay, Debanjan, et al.
Publicado: (2020)

Toxoplasma GRA15 and GRA24 are important activators of the host innate immune response in the absence of TLR11
por: Mukhopadhyay, Debanjan, et al.
Publicado: (2020)

Application of Toxoplasma gondii-specific SAG1, GRA7 and BAG1 proteins in serodiagnosis of animal toxoplasmosis
por: Qi, Tongsheng, et al.
Publicado: (2022)

The GRA17 Parasitophorous Vacuole Membrane Permeability Pore Contributes to Bradyzoite Viability
por: Paredes-Santos, Tatiana, et al.
Publicado: (2019)

Testing New Peptides From Toxoplasma gondii SAG1, GRA6, and GRA7 for Serotyping: Better Definition Using GRA6 in Mother/Newborns Pairs With Risk of Congenital Transmission in Mexico
por: Xicoténcatl-García, Lizbeth, et al.
Publicado: (2019)

Protective efficacy of Toxoplasma gondii GRA12 or GRA7 recombinant proteins encapsulated in PLGA nanoparticles against acute Toxoplasma gondii infection in mice
por: Sun, Hong-chao, et al.
Publicado: (2023)

Protective immunity induced by DNA vaccine containing TgGRA35, TgGRA42, and TgGRA43 against Toxoplasma gondii infection in Kunming mice
por: Shi, Youbo, et al.
Publicado: (2023)

Toxoplasma Effector GRA15-Dependent Suppression of IFN-γ-Induced Antiparasitic Response in Human Neurons
por: Bando, Hironori, et al.
Publicado: (2019)

Editorial: Insights in Toxoplasma Biology and Infection—15th Biennial Meeting on Toxoplasma Biology and Toxoplasmosis
por: Gomez-Marin, Jorge Enrique, et al.
Publicado: (2021)

Enhancing Immune Responses to a DNA Vaccine Encoding Toxoplasma gondii GRA7 Using Calcium Phosphate Nanoparticles as an Adjuvant
por: Sun, Hong-Chao, et al.
Publicado: (2021)

In vitro and in vivo anti−Toxoplasma activities of HDAC inhibitor Panobinostat on experimental acute ocular toxoplasmosis
por: Zhang, Yu, et al.
Publicado: (2022)

Influence of Two Major Toxoplasma Gondii Virulence Factors (ROP16 and ROP18) on the Immune Response of Peripheral Blood Mononuclear Cells to Human Toxoplasmosis Infection
por: Hernández-de-los-Ríos, Alejandro, et al.
Publicado: (2019)

New Avenues to Design Toxoplasma Vaccines Based on Oocysts and Cysts
por: Arranz-Solís, David, et al.
Publicado: (2022)

Use of in vitro derived human neuronal models to study host-parasite interactions of Toxoplasma gondii in neurons and neuropathogenesis of chronic toxoplasmosis
por: Halonen, Sandra K.
Publicado: (2023)

A Protective and Pathogenic Role for Complement During Acute Toxoplasma gondii Infection
por: Sikorski, Patricia M., et al.
Publicado: (2021)

Cloning and expression of Toxoplasma gondii GRA-4 recombinant protein as a toxoplasmosis diagnostic kit candidate
por: Hanafiah, Muhammad, et al.
Publicado: (2020)

Strain-specific activation of the NF-κB pathway by GRA15, a novel Toxoplasma gondii dense granule protein
por: Rosowski, Emily E., et al.
Publicado: (2011)

CRISPR screen to determine the in vivo fitness of Toxoplasma genes
por: Sangaré, Lamba Omar, et al.
Publicado: (2021)

Toxoplasma GRA15 Activates the NF-κB Pathway through Interactions with TNF Receptor-Associated Factors
por: Sangaré, Lamba Omar, et al.
Publicado: (2019)

The Toxoplasma Polymorphic Effector GRA15 Mediates Seizure Induction by Modulating Interleukin-1 Signaling in the Brain
por: Glausen, Taylor G., et al.
Publicado: (2021)

Review on the Current Trends of Toxoplasmosis Serodiagnosis in Humans
por: Ybañez, Rochelle Haidee D., et al.
Publicado: (2020)

Late Embryogenesis Abundant Proteins Contribute to the Resistance of Toxoplasma gondii Oocysts against Environmental Stresses
por: Arranz-Solís, David, et al.
Publicado: (2023)

Genome-wide CRISPR screen identifies genes synthetically lethal with GRA17, a nutrient channel encoding gene in Toxoplasma
por: Paredes-Santos, Tatiana C., et al.
Publicado: (2023)

Implications of TORCH Diseases in Retinal Development—Special Focus on Congenital Toxoplasmosis
por: de Campos, Viviane Souza, et al.
Publicado: (2020)

Evaluation of Serological and Molecular Tests Used for the Identification of Toxoplasma gondii Infection in Patients Treated in an Ophthalmology Clinic of a Public Health Service in São Paulo State, Brazil
por: Murata, Fernando Henrique Antunes, et al.
Publicado: (2020)

A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for Toxoplasmosis
por: Rocha-Roa, Cristian, et al.
Publicado: (2018)

Immunomodulatory Effects of the Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide in Acute Toxoplasmosis
por: Figueiredo, Caio Andreeta, et al.
Publicado: (2019)

In vitro Evaluation of Mannosylated Paromomycin-Loaded Solid Lipid Nanoparticles on Acute Toxoplasmosis
por: Khosravi, Mojdeh, et al.
Publicado: (2020)

Protein kinases on carbon metabolism: potential targets for alternative chemotherapies against toxoplasmosis
por: dos Santos, Denis Amilton, et al.
Publicado: (2023)

RHΔgra17Δnpt1 Strain of Toxoplasma gondii Elicits Protective Immunity Against Acute, Chronic and Congenital Toxoplasmosis in Mice
por: Liang, Qin-Li, et al.
Publicado: (2020)

Evaluation of Immunoprotection Conferred by the Subunit Vaccines of GRA2 and GRA5 against Acute Toxoplasmosis in BALB/c Mice
por: Ching, Xiao T., et al.
Publicado: (2016)

Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis
por: Bastos, Luciana M., et al.
Publicado: (2016)

Disease Tolerance in Toxoplasma Infection
por: Melchor, Stephanie J., et al.
Publicado: (2019)

Phylogeography of Human and Animal Coxiella burnetii Strains: Genetic Fingerprinting of Q Fever in Belgium
por: Tomaiuolo, Sara, et al.
Publicado: (2021)

DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice
por: Sun, Xi-Meng, et al.
Publicado: (2011)

Outbreak of Amazonian Toxoplasmosis: A One Health Investigation in a Remote Amerindian Community
por: Blaizot, Romain, et al.
Publicado: (2020)

Tityus serrulatus (Scorpion): From the Crude Venom to the Construction of Synthetic Peptides and Their Possible Therapeutic Application Against Toxoplasma gondii Infection
por: de Assis, Diego Rodney Rodrigues, et al.
Publicado: (2021)

Early Kinetics of Intestinal Infection and Immune Responses to Two Toxoplasma gondii Strains in Pigs
por: Rahman, Mizanur, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_64kgld583v1ltlg68jc1ao754c